Related Experiment Video

Updated: Aug 23, 2026

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs)

Anette Duensing1, Nora E Joseph, Fabiola Medeiros

  • 1Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. aduensin@pitt.edu

Cancer Research
|August 4, 2004
PubMed

Insights

Protein kinase C theta (PKCtheta) is a novel diagnostic marker for gastrointestinal stromal tumors (GISTs). This finding aids in diagnosing GISTs, even those lacking KIT expression, and suggests PKCtheta as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gastrointestinal stromal tumors (GISTs) are typically diagnosed by KIT expression.
  • Oncogenic KIT or PDGFRA mutations drive GIST development and are targeted by imatinib therapy.
  • Low KIT expression in PDGFRA-mutant GISTs can lead to misdiagnosis as other sarcomas.

Purpose of the Study:

  • To identify novel diagnostic markers for GISTs.
  • To investigate the role of protein kinase C theta (PKCtheta) in GIST diagnosis.
  • To explore PKCtheta as a potential therapeutic target in GISTs.

Main Methods:

  • Analysis of KIT expression in GIST samples.
  • Assessment of PDGFRA mutations in GISTs.
  • Evaluation of PKCtheta activation as a diagnostic marker.

Main Results:

  • PKCtheta is identified as a diagnostic marker in GISTs.
  • PKCtheta is activated in GISTs, including those with low KIT expression or PDGFRA mutations.
  • PKCtheta shows potential as a diagnostic tool for challenging GIST cases.

Conclusions:

  • PKCtheta serves as a reliable diagnostic marker for GISTs, irrespective of KIT expression levels or PDGFRA mutations.
  • PKCtheta activation is a common feature across most GISTs.
  • PKCtheta represents a promising novel therapeutic target for GIST treatment.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...